BeOne Medicines (STU:49B) Change In Other Working Capital : €64 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is BeOne Medicines Change In Other Working Capital?

BeOne Medicines's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €31 Mil. It means BeOne Medicines's Other Working Capital increased by €31 Mil from Dec. 2024 to Mar. 2025 .

BeOne Medicines's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €30 Mil. It means BeOne Medicines's Other Working Capital increased by €30 Mil from Dec. 2023 to Dec. 2024 .

BeOne Medicines Change In Other Working Capital Historical Data

The historical data trend for BeOne Medicines's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeOne Medicines Change In Other Working Capital Chart

BeOne Medicines Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

-13.31

263.69

-147.56

-222.72

29.53

BeOne Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															-4.66	-25.83	38.06	20.58	31.25

BeOne Medicines Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €64 Mil.

BeOne Medicines Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of BeOne Medicines's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

BeOne Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeOne Medicines Ltd (STU:49B) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

BEIGF:USA ONC:USA 06160:Hong Kong 688235:China B1ME34:Brazil

Address

c/o BeOne Medicines I GmbH, Aeschengraben 27, 21st Floor, Basel, CHE, 4051

Website

https://www.beonemedicines.com

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

BeOne Medicines Headlines

No Headlines